This report provides exclusive insights into the COVID-19 impact on the Liver Fibrosis Drug Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Liver Fibrosis Drug Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Liver Fibrosis Drug Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on liver
fibrosis drug market provides an in-depth analysis of segments and sub-segments in
the global as well as regional liver fibrosis drug market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional liver fibrosis drug market over the short term as well as
long term. The report is a comprehensive presentation of trends, forecast and
dollar values of the global liver fibrosis drug market. According to the report,
the global liver fibrosis drug market is projected to grow at a CAGR of 10.7%
over the forecast period of 2019-2025.
Liver fibrosis drugs are used when there is the formation of
excessive amounts of scar tissue in the organ due to repetitive or long-lasting
injury or inflammation. Various types of chronic liver disease eventually cause
fibrosis. These drugs are applicable to treat biliary fibrosis, parasitic
infection fibrosis, metabolic fibrosis alcoholic fibrosis, viral hepatitis
fibrosis, intoxication fibrosis, cardiogenic fibrosis, and alcoholic fibrosis.
Hospitals and clinics are major users of liver fibrosis drugs.
The rising prevalence of liver fibrosis and liver diseases
drives the growth of the liver fibrosis drug market. There are around 2 million
deaths per year worldwide. In addition, the factors such as increasing
government funding for treatment of liver fibrosis and liver diseases, growing
geriatric population and increasing health awareness contribute to the growth
of the liver fibrosis drug market. As per the World Health Organization, the
world’s population over 60 years will be 22%. The increasing consumption of
alcohol and unhealthy diet habits increases the cases of liver fibrosis that
boosts the demand for liver fibrosis market. On the other hand, strict
government regulations for drug approval and the risk of side effects from the
use of these drugs restrains the growth of the liver fibrosis drug market.
Moreover, research and development to innovate new drugs create numerously
opportunities for the liver fibrosis drug market.
North America holds a larger share in the global liver
fibrosis drug market. North America has an increasing number of patients with
liver fibrosis contributing to the growth of the liver fibrosis drug market.
Asia-Pacific region is anticipated to grow in the liver fibrosis drug market.
In the Asia-Pacific region, there will be 1.3 billion people age above 60 years
The report on global liver fibrosis drug market covers segments
such as drug class, and distribution channel. On the basis of drug class, the
sub-markets include interferon (IFN) therapy, nucleoside analog, maloti lipid,
and other drug classes. On the basis of distribution channel, the sub-markets
include hospital pharmacies, retail pharmacies, and online pharmacies.
The report provides profiles of the companies in the market such
as Dicerna Pharmaceuticals, Inc., Pharmaxis Limited, Celgene Corporation,
Dynavax Technologies Corporation, Mirum Pharmaceuticals, Gilead Sciences, Inc.,
Merck & Co., Inc., Johnson and Johnson, Novartis AG, and Other
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of liver fibrosis
drug market. Moreover, the study highlights current market trends and provides
forecast from 2019-2025. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight into the market share
of the leading players.